At present, the mechanisms by which general anesthetics causing loss of consciousness remain unclear. The central medial thalamic nucleus (CMT) is a rarely studied component of the midline thalamic complex, which is deemed to be a part of the nonspecific arousal system. Although the CMT participates in modulating arousal and receives excitatory noradrenergic projections from locus coeruleus, it remains unknown whether the noradrenergic pathway in the CMT takes part in modulating the arousal system. Therefore, we hypothesized that noradrenergic transmission in the CMT is involved in modulating induction and emergence of propofol anesthesia. First, we infused norepinephrine (NE) into the CMT to observe the role of CMT noradrenergic pathway in modulating the anesthetic state induced by propofol. The results showed that microinjection of NE into the CMT accelerated emergence from propofol anesthesia, but had no impact on the induction of or sensitivity to propofol anesthesia in rats. In addition, infusion of NE into the CMT caused electroencephalography changes in the prefrontal cortex and the anterior cingulate cortex. Finally, we used a whole-cell patch clamp to examine the effects of NE on neuronal excitability and GABAergic transmission in the CMT. In the CMT slices, propofol suppressed neuronal excitability and enhanced GABAergic transmission, while application of NE partly reversed these effects. These findings support the hypothesis that the CMT noradrenergic pathway plays an important role in modulating the emergence from general anesthesia.
The question of how general anesthetics induce loss of consciousness (LOC) and maintain anesthetic states is fundamental to both medicine and neuroscience (Kennedy and Norman 2005) . Molecular targets for general anesthetics include GABA A , NMDA, nicotinic and cholinergic receptors, and two-pore (K + ) channels (Franks 2008) . However, how general anesthetics act on these targets and induce LOC is not completely understood.
Alkire and colleagues have proposed that general anesthetics primarily influence integrative processes, rather than simply disrupting sensory transmission during induced LOC (Alkire et al. 2008) . The thalamocortical system has been shown to play a critical role in the integration of information (Edelman 2003; Tononi and Koch 2008) . In particular, the midline thalamic complexes, which are part of the nonspecific thalamocortical system, have been implicated in modulating cortical synchrony, information transmission and cognition (Saalmann 2014) . The central medial thalamic nucleus (CMT) is a rarely studied component of the midline thalamic nuclei, which are considered to be part of the nonspecific arousal system ( Van der Werf et al. 2002) . The CMT has been shown to act as a key hub in propofol induced loss of righting reflex (LORR) in rats (Baker et al. 2014) . Moreover, CMT infusion of nicotine has been shown to elicit both behavioral and electroencephalographic arousal from deep sevoflurane anesthesia (Baker et al. 2014) . Likewise, microinjection of ShK (a potent inhibitor of Kv1 channels) into the CMT is sufficient to awaken sevoflurane anesthetized rats (Lioudyno et al. 2013) . These studies suggest that the CMT participates in modulating arousal from general anesthesia.
The excitatory neurotransmitter norepinephrine (NE) is a crucial modulator of the ascending arousal system (Franks 2008) , which originates primarily from the locus coeruleus (LC) located in the pontine (Foote et al. 1983) . Activation of LC-NE neurons drives cortical arousal and the emergence from isoflurane anesthesia (Vazey and Aston-Jones 2014) . The CMT has been shown to receive noradrenergic afferents from the LC (Jones and Yang 1985) . Although the CMT takes part in modulating arousal and receives excitatory noradrenergic projections from the LC, it remains unknown whether noradrenergic pathway in the CMT participates in modulating the arousal system. Therefore, we hypothesized that noradrenergic transmission in the CMT is involved in modulating induction and emergence of propofol anesthesia. The purpose of this study was to determine the role of noradrenergic transmission in the CMT in modulating the state of propofol anesthesia in rats. Therefore, we first observed the behavioral effects of microinjection of NE into the CMT under propofol anesthesia. We then examined the changes in EEG activity caused by administration of NE into the CMT of propofol-anesthetized rats. Finally, we observed the impact of NE on GABAergic transmission and neuronal activity in the CMT using whole-cell patch-clamp recording. Our results show that microinjecting NE into the CMT induces changes in EEG and facilitates emergence from propofol anesthesia in rats, but has no impact on induction of or sensitivity to propofol anesthesia in rats. Furthermore, we show that CMT neurons are depolarized by propofol and hyperpolarized by NE, while propofol-induced enhancement of GABAergic neurotransmission is partly reversed by NE.
Materials and Methods

Animals
All experimental and surgical procedures were approved by the Animal Care and Use Committees of Zunyi Medical University, Guizhou, China. Eighty-one Sprague-Dawley male rats (250-300 g, approximately 9-12 weeks old) and 50 infant male rats (10-20 days old) were obtained from the Animal Center of Third Military Medical University (license number: SCXK2007-0005; Chongqing, China). All rats received humane care in compliance with the 'Guide for the care and use of laboratory animals ' in China (No. 14924, 2001 ). Rats were housed in an ambient temperature of 22 AE 0.5°C with a relative humidity (60 AE 2%) on an automatically controlled 12 h light/12 h dark cycle (light on at 8:00 am). All rats had free access to purified water and a standard chow diet.
Surgery
For all experiments, adult male rats were maintained in the SPF laboratory animal room of Zunyi Medical University for 1 week before surgery. Rats were intraperitoneally anesthetized with sodium pentobarbital (50 mg/kg) and intraperitoneally administered 0.2 mg atropine sulfate. Rats were placed into a stereotaxic frame (Stoelting Company, Wood Dale, Illinois, USA). Sterile 2.0% lidocaine was injected subcutaneously for local anesthesia. An incision was made along the midline and the surface of the skull was exposed. Hydrogen peroxide was used to stop the bleeding. A guide cannula (O.D. 0.48 mm 3 I.D. 0.34 mm, length: 6.0 mm) was implanted into the CMT [anteroposterior (AP) À3.2 mm from bregma; mediolateral (ML) + 0.2 mm from the midline; dorsoventral (DV) À6.5 mm from skull surface], according to stereotactic coordinates from the rat brain atlas (Paxinos & Watson, 2005) . The rat brain in stereotaxic coordinates, 5th ed., Academic Press, New York.
In addition to the guide cannula in the CMT, two EEG electrodes were implanted over the left prefrontal cortex (PFC, 3.7 mm AP, 3.2 mm ML, 2.0 mm DV) and the anterior cingulate cortex (ACC, 3.0 mm AP, À0.8 mm ML, 2.3 mm DV), in another 12 rats. The guide cannula and EEG electrodes were immobilized in place with dental acrylic and two small skull screws.
Before removing from the stereotaxic frame, a dummy inner cannula (length: 6.0 mm) was inserted into the guide cannula and the screw cap was tightened. Carprofen (5 mg/kg) and enrofloxacin (10 mg/kg) were subcutaneously administered once daily for postoperative 2 and 7 days, respectively. Rats were housed individually to decrease the incidence of cases in which the skullcap was removed. All rats were allowed 7 days to recover before subsequent experiments.
Drug preparation and administration
L-(À)-norepinephrine (+)-bitartrate salt monohydrate(NE, SigmaAldrich, St. Louis, Missouri, USA) was dissolved in artificial cerebrospinal fluid (ACSF), containing: 124 mM NaCl, 2.5 mM KCl, 1.25 mM NaH 2 PO 4 , 26 mM NaHCO 3 , 1 mM MgCl 2 , 2 mM CaCl 2 , and 10 mM glucose, pH 7.2, 300 mOsm. We tested four different concentrations of NE in three pilot rats (n = 3), which did not participate in the study. We found that 0.1 lg/lL NE failed to elicit emergence and that higher doses of NE (2.0 lg/lL) caused detrimental side effects (limb tremor and seizure) ( Figure S1a ). A dose of 1.0 lg/lL NE significantly accelerated emergence, and did not cause any detrimental side effects. Therefore, a dose of 1.0 lg/ lL NE was chosen for use in this study.
The infusion cannula (length: 6.5 mm) and the PE50 tubing were connected to a 10 lL Hamilton syringe. The drug was delivered by a microinjection pump (RWD302, RWD Company, Shenzhen, China). NE and ACSF were infused at a rate of 0.25 lL/min for 2 min (total infused volume: 0.5 lL). Experimental rats were randomly divided into two groups: a NE group and an ACSF (control) group. In order to reduce the number of experimental rats used, each animal was infused multiple times. The time interval between any two infusions was always longer than 3 days. All efforts were made to minimize the number of rats used.
Experimental protocol in vivo
After surgery, all rats were numbered and were randomly divided into two groups: a NE group and an ACSF group (control group), using the table of random numbers by a man who did not take part in this study. In behavioral experiments and anesthetic sensitivity tests, the observers did not know the component of infusion or the group of rats. In order to minimize the confounding effects of time on the experimental results, all behavioral and EEG experiments were performed between 8:00 pm and 11:00 pm at night. Before receiving treatment, rats were transferred into a transparent Plexiglas anesthesia induction chamber (50 9 30 9 30 cm) (RWD Company, Shenzhen, China). For the in vivo experiments, we measured the loss and recovery of the righting reflex, which is commonly used in rats as a surrogate index to measure the loss and recovery of consciousness respectively (Alkire et al. 2007; Franks 2008; Hudetz et al. 2011) .
Anesthetic response to propofol
After a 10-min acclimation period in the Plexiglas chamber, NE (0.5 lL, 1.0 lg/lL) was microinjected into the CMT. Anesthetic responses to propofol were measured using a cumulative dose method, as previously described (Udesky et al. 2005; Luo and Leung 2011) . After ending microinfusion, a rat immediately received multiple intraperitoneal injections with propofol, beginning at 40 mg/kg and increasing by 20 mg/kg, every 10-min, until a dose of propofol had been reached that resulted in a LORR. A rat was considered to have a LORR if it could not turn on all four limbs within 30 s. For each dose, two trials were performed. The dose-LORR relationship was fitted by a curve with the equation:
, where X is the logarithmic propofol dose, Y is the percentage of the population anesthetized, m is the slope parameter, and ED50 is the propofol dose generating the half-maximal effect.
Quantification of induction time for propofol anesthesia Each rat was put into an induction chamber to acclimate for 10 min ( Fig. 1a ; t = À10 min). NE or ACSF (0.5 lL) was infused into the CMT for 2 min ( Fig. 1a ; t = 0 min). At the end of microinjection, anesthesia induction began ( Fig. 1a ; t = 2 min) by continuous intravenous infusion of propofol (48 mg/kg/h), as described previously (Vanini et al. 2014) . The anesthesia induction time was defined as the time to LORR in minutes. The time to LORR was quantified as the duration from the beginning of the continuous intravenous infusion of propofol to the time at which the rat first demonstrated LORR for more than 30 s.
Quantification of emergence time from propofol anesthesia Rats were first acclimated to the induction chamber ( Fig. 1b ; t = À10 min). Ten minutes later, rapid anesthesia induction began ( Fig. 1b ; t = 0 min) by injecting propofol (11 mg/kg) through the caudal vein within 30 s. One minute after induction, anesthetic maintenance began ( Fig. 1b ; t = 1 min) by continuous intravenous infusion of propofol (48 mg/kg/h). Anesthetic maintenance lasted for 30 min to make sure that the concentration of propofol in the brain had equilibrated (Dutta et al. 1997) . As illustrated in Fig. 1 (b), 2 min before discontinuing propofol infusion, each rat received a microinjection of NE or ACSF (0.5 lL) into the CMT ( Fig. 3b ; t = 28 min to t = 30 min). The rate and volume of microinjection were equivalent to those used in the induction protocol. At the end of propofol infusion, rats were positioned in a supine position. Emergence time (in minutes) from propofol anesthesia was calculated by measuring the time taken for a return of the righting reflex (RORR). In other words, the emergence time was equal to the total duration between the time of discontinuing propofol infusion and the time that the rat could right itself fully and place four feet on the floor. For all behavioral experiments, rats stayed in the chamber during the induction, maintenance, and emergence periods.
EEG recording and analyses EEG signals were collected using a CED Power1401-3 device (Cambridge Electronic Design, Cambridge, UK) and were amplified by amplifiers (3000; A-M Systems, Inc., Washington, USA). EEG signals were recorded on a computer with the Spike 2 software package (Cambridge Electronic Design). The high-pass filter was set at 0.1 Hz and the low-pass filter was set at 0.3 kHz. EEG recordings were performed before and after infusion. Power spectrum analysis was conducted on data from the 10 min before and after microinjections. Relative powers in the different frequency bands were calculated by averaging the signal power across the frequency range of each band (d: 1-4 Hz; h: 4-8 Hz; a: 8-12 Hz; b: 12-25 Hz; and c: 25-60 Hz) and then dividing by the total power from 1 to 60 Hz. There is a dip at 50 Hz of the power spectra. We used a notch filter to remove the line (50 Hz) frequency while drafting the logarithmic power spectra of EEG. However, the results of the power spectra at 50 Hz were included in statistical analysis.
Histological localization of the microinjection site After behavioral and EEG testing, rats were intraperitoneally anesthetized with sodium pentobarbital (60 mg/kg) and perfused with 0.9% saline through the heart, followed by 4% paraformaldehyde. Brains were first fixed in 4% paraformaldehyde overnight at 4°C, and then dehydrated in 30% sucrose at 4°C for 3-5 days. Blocks containing the CMT were cut into 60 lm coronal sections on a freezing microtome (Leica, Heidelberg, Germany). All sections containing the CMT were mounted on glass slides, then dried and stained with 1% eosin staining solution. The coordinates of the microinjection sites were confirmed by reference to the rat brain atlas (Paxinos & Watson, 2005) .
Whole-cell patch-clamp recording in brain slices
Brain slice preparation Rats (10-20 days old) were deeply anesthetized with sevoflurane and then decapitated. The brains were cut into 250 lm-thick coronal slices with a vibrating microtome (HM650V; Thermo Fisher Scientific, Waltham, MA ,USA) while submerged in ACSF. After cutting, brain slices were gently transferred to an incubating chamber where the temperature was maintained at 32°C for 30 min and then lowered to 28°C. Before recording, brain slices were allowed to recover for 1 h in the incubating chamber.
Whole-cell current-clamp recordings
The slice to be recorded was transferred into a recording chamber filled with ACSF saturated with 95% O 2 and 5% CO 2 . CMT neurons were visually identified using a BX51WI microscope (Olympus, Tokyo, Japan) equipped with infrared-differential interference contrast optics as described previously (Belelli and Herd 2003) . The micropipette (4-6 MΩ) was pulled from glass capillaries (Sutter Instruments, Novato, CA, USA) and filled with an internal solution containing the following 10 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid; 10 mM KCl, 130 mM K-gluconate, 2 mM MgCl 2 , 2 mM ATP-Mg, and 0.2 mM GTP-tris (hydroxy-methyl) aminomethane (pH 7.2; 280 mOsm). To record the firing of CMT neurons, we applied depolarizing current pulses (100 pA, 500 ms in duration).
Whole-cell voltage-clamp recordings
To isolate GABAergic spontaneous inhibitory postsynaptic currents (sIPSCs), 1 lM strychnine (a selective glycine receptors antagonist; Sigma-Aldrich) and 2 mM kynurenic acid (a glutamate receptors antagonist; Sigma-Aldrich) were diluted in ACSF and the membrane potential was maintained at À70 mV (Eckle et al. 2015) . The intracellular solution for recording sIPSCs contains (in mM): 140 mM CsCl, 10 mM Hepes, 10 mM EGTA, 2 mM MgATP, 1 mM CaCl2, pH 7.3, and 300-305 mOsm, as our previous described (Fu et al. 2016) . All data were acquired via a HEKA EPC10 amplifier (HEKA Instruments, Inc., Lambrecht, Germany), as previously described . For currents recording, the basal noise values were < 10 pA.
Drug application
During the experiments, ACSF was continuously equilibrated with 95% O 2 and 5% CO 2 . Propofol (2,6-diisopropylphenol; Fresenius, Beijing, China) and NE were administered via a rapid BPS-4 perfusion system (ALA, Farmingdale, NY, USA), which could completely replace the solution surrounding the recorded neurons within 1 min. Propofol and NE were prepared before each experiment, diluted to the appropriate concentrations in ACSF. In order to determine an effective concentration of propofol for use in this study, we measured the effect of four different concentrations (1 lM, 10 lM, 100 lM, and 1000 lM) of propofol on the firing frequency of CMT neurons. The result showed that 10 lM, 100 lM, and 1000 lM propofol significantly decreased the firing rate of CMT neurons in a concentration-dependent manner (p < 0.05, n = 3, Figure S1b ). After application of 1000 lM propofol, the firing of CMT neurons became unstable. Therefore, we selected 100 lM as the concentration for patch-clamp experiments in this study. The concentration of NE was the same as used for microinjection, namely 1 lg/lL. We began to record currents after a 5-min period following drug perfusion and the recording time lasted for 5 min. All spontaneous synaptic currents were detected and analyzed from digitized waveforms using Mini Analysis 6 (Synaptosoft, Inc., Decatur, GA, USA), as described previously (Jang et al. 2002) . The amplitude threshold of currents was set to 20 pA. The amplitude and frequency of currents were normalized to their mean value during the control period (5 min). The effects of drugs were expressed as % change (mean AE SEM) from pre-drug baseline, due to the large variability observed from neuron to neuron.
Statistical analyses
All statistical analyses were performed using the GraphPad Prism software package version 5.0 (GraphPad Software Inc., San Diego, CA, USA). Data is presented as mean AE SEM or the median with the interquartile range. The differences in ED50 values between the ACSF and NE groups were analyzed using unpaired Student's t-tests. LORR and RORR times for propofol anesthesia were analyzed using non-parametric (Mann-Whitney) tests. The effect of NE on EEG power was evaluated using paired t-tests. Repeatedmeasures one-way ANOVAs with post-hoc Bonferroni's correction were used to analyze data from propofol and NE. In all cases, p < 0.05 was considered significant.
Results
Histological localization
After behavioral tests, the infusion sites of rats were verified. If a rat's cannula does not successfully target the CMT, a substitute will receive the cannula implantation. Twenty-six rats were used to test the anesthetic response to propofol. Twenty rats with cannula sites were in the CMT and five rats with cannula sites were outside of the CMT (two from ACSF group, three from NE group). In addition, one rat was dropped and executed under sevoflurane anesthesia, because the cannula implant became detached after surgery. In total, 40 rats took part in the behavioral (LORR and RORR) and EEG tests. As shown in Fig. 1(c) , the infusion sites were within the CMT in 32 rats, and outside the CMT in six rats (two from ACSF group, four from NE group). Two rats were dropped and executed under sevoflurane anesthesia, because the cannula implants became detached following surgery. Finally, each group contained 10 rats in behavioral tests (n = 10) and contained six rats in EEG measures (n = 6). The sample size was determined based on the preliminary experimental data. The required sample size for analyzing the difference of EEG between pre-and postinfusion of NE was estimated using the PASS 11. NCSS software (LLC, Kaysville, UT, USA). The result showed that N value is 6. Hence, the sample size used in this study can meet the requirement of expected effect size. The number of rats used in every experiment is showed in Figure S2 .
The histological slice in Fig. 1(d) shows a representative example of the microinfusion cannula successfully targeting the CMT. Rats with cannula sites outside of the CMT were not included in the results.
NE infusion into the CMT did not change anesthetic sensitivity to propofol As shown in Fig. 2(a) , the ED50 for the induction of propofol anesthesia by intraperitoneal injection was similar whether NE or ACSF was microinjected into the CMT (NE: 92.69 AE 4.27 vs. ACSF: 94.66 AE 3.76; p > 0.05, n = 10). This result indicated that compared to the ACSF group, NE infusion into the CMT did not change anesthetic sensitivity to propofol in rats.
NE infusion into the CMT did not alter induction time, but shortened the emergence time from propofol anesthesia In this study, we used a dose of 11 mg/kg propofol for rapid induction. In order to determine the optimal induction dose, we used a range of doses of propofol (5-15 mg/kg) to anesthetize rats (n = 6). We found that a low dose of propofol (≤ 10 mg/kg) did not result in LORR for all rats, whereas a high dose of propofol (11-15 mg/kg) led to a 100% LORR rate within 30 s, as shown in Fig. 2(b) . However, some rats died from circulatory and respiratory inhibition when the propofol dose was higher than 11 mg/kg. For this reason, we determined 11 mg/kg of propofol to be the optimal induction dose. No rats died as a result of using this dose in the subsequent experimental trials.
LORR and RORR in rats have been used as a surrogate measure for the loss and resumption of consciousness under anesthesia in human (Franks 2008) . Figure 1(a) illustrates the experimental protocol used to quantify the time to LORR for propofol anesthesia. As shown in Fig. 2(c Figure 1(b) shows the experimental protocol used to quantify the time to RORR for propofol anesthesia. Our results showed that compared to ACSF group, microinjection of NE into the CMT significantly shortened the recovery time from propofol anesthesia [ Fig. 2d ; ACSF: 26.01 min (IQR: 23.07-30.811 min) vs. NE: 16.10 min (IQR: 12.74-19.75 min); p < 0.05, n = 10]. Therefore, these results suggest that microinjection of NE into the CMT did not affect the induction time of propofol anesthesia, but did accelerate emergence from propofol anesthesia.
Administration of NE into the CMT induced spectral changes in the EEG, without changing the respiratory rate Given that infusion of NE into the CMT accelerated recovery from propofol anesthesia, we next sought evidence of cortical arousal in 12 rats implanted with electrodes targeted at the PFC and ACC. Twelve rats were also were randomly divided into the NE group and ACSF group (six rats per group) by the means of the table of random numbers.
We tested the effect of microinjection of NE into the CMT on spontaneous EEG activity in these regions in rats under continuous propofol anesthesia (48 mg/kg/h). As illustrated in Figs 3 and 4 , spectral analyses of EEG data showed that slow waves (d: 1-4 Hz) had the highest power in PFC (47.59 AE 6.60%) and ACC (41.06 AE 6.56%) under continuous propofol anesthesia. Surprisingly, infusion of NE did not change the power ratio of the d frequency band, but did increase the power ratio in the h band (4-8 Hz) in PFC ( Fig. 3d; propofol: 13.87 AE 1.30% vs. NE: 18.47 AE 2.16%; p < 0.05, n = 6). Infusion of ACSF into the CMT did not cause the EEG changes in PFC (Fig. 3b) .
However, injection of NE into the CMT significantly decreased the relative power in ACC in the d band ( Fig. 4d; propofol: 41.06 AE 6.56% vs. NE: 33.95 AE 6.36%; p < 0.05, n = 6), and increased relative power in the h band (propofol: (d) However, the emergence time from propofol anesthesia was significantly shortened, as measured by % return of righting reflex (RORR) (p < 0.05; n = 10). *p < 0.05. Fig. 3 (a) Representative EEG activity traces and corresponding power spectra recorded in the prefrontal cortex before and after infusion of (a) Artificial cerebrospinal fluid (ACSF) or (c) Norepinephrine (NE). (b) Spectral analyses of EEG power showed that ACSF had no effect on the power in any of the frequency bands quantified. (d) In contrast, infusion of NE increased h (4-8 Hz) power. Data shown in the spectral power ratio analyses are mean AE SEM (n = 6). *p < 0.05; paired t-tests on data before versus after infusion.
14.96 AE 1.83% vs. NE: 17.76 AE 2.14%; p < 0.05, n = 6) and a band (8-12 Hz; propofol: 14.96 AE 1.83% vs. NE: 17.76 AE 2.15; p < 0.05, n = 6). In contrast, NE did not affect fast waves (b: 12-25 Hz; c: 25-60 Hz) in either the PFC or ACC (Figs 3 and 4) . The EEG in ACC was not significantly altered after ASCF (artificial cerebrospinal fluid) infusion (Fig. 4b) .
We also measured changes in respiratory activity before and after infusion of NE, but found that microinjection of NE into the CMT did not affect the respiratory rate ( Figure S1c ). In addition, we measured the EEG changes in ACC during rats recovered normally from propofol (without NE) in another six rats (n = 6). Relative to propofol, the power ratio of ds declined significantly, while there was a marked increase in h, a and b power during emergence ( Figure S1d) . Infusion of NE caused EEG changes are similar to emergency, but the changes are lower than that during recovery from propofol ( Figure S1d ).
Application of NE partly reversed propofol-induced inhibition of CMT neurons
We used whole-cell current-clamp recording to measure the effect of propofol or NE on the membrane potential and firing rate of CMT neurons. Compared to baseline, 100 lM propofol resulted in a significant hyperpolarization of the membrane potential ( Fig. 5c ; baseline: À66.4 AE 1.02 mV vs. propofol: À71.3 AE 0.80 mV; p < 0.01, n = 7). However, after bath application of 3.13 mM NE (equivalent to 1.0 lg/lL), neurons were depolarized to À67.4 AE 0.99 mV (p < 0.05, compared to propofol). Similarly, whereas addition of 100 lM propofol decreased the firing frequency induced by a depolarization current (baseline: 44.86 AE 4.84 Hz vs. propofol: 27.14 AE 2.49 Hz, p < 0.05, n = 7), administration of NE partly reversed this inhibitory effect (propofol: 27.14 AE 2.49 Hz vs. NE: 35.43 AE 1.51 Hz; p < 0.05, n = 7, Fig. 5d ).
NE partly decreased the facilitated effects of propofol on GABAergic transmission
We also used whole-cell voltage-clamp recording to observe the effect of NE on spontaneous GABAergic sIPSCs. We successfully recorded six data sets from 67 neurons and we also used bicuculline to verify the currents that are mediated by GABA A receptors (Fig. 6a) . As shown in Fig. 6(b) , the frequency of sIPSCs increased to 155.89 AE 11.56% relative to baseline after administration 100 lΜ propofol (p < 0.01, n = 6), while application of NE decreased the frequency to 122.28 AE 5.11% (p < 0.05, n = 6, relative to propofol). There is no significant difference between the baseline and propofol plus NE group ( Fig. 6b ; p > 0.05, n = 6).
Bathing the neurons in 100 lΜ propofol also increased the amplitude of sIPSCs to 130.29 AE 5.7% of baseline (p < 0.01, n = 6), but NE did not affect the amplitude of sIPSCs ( Fig. 6c ; p > 0.05, n = 6). Based on these results, we conclude that NE partly reversed the facilitatory effects of propofol on GABAergic transmission through a primarily presynaptic mechanism.
Discussion
The results of this study show that microinjection of NE into the CMT induces spectral changes in the EEG and Fig. 4 Representative traces of EEG activity and corresponding power spectra recorded in the anterior cingulate cortex before and after infusion of (a) Artificial cerebrospinal fluid (ACSF) or (c) Norepinephrine (NE). (b) Spectral analyses of EEG power showed that ACSF had no effect on any of the frequency bands quantified. (d) However, infusion of NE decreased d (1-4 Hz) power, and increased h (4-8 Hz) and a (8-12 Hz) power. Data shown in the spectral power ratio analyses are mean AE SEM (n = 6). *p < 0.05; paired t-tests on data before versus after infusion.
accelerates emergence from propofol anesthesia, without affecting the respiratory rate. Furthermore, electrophysiological measurements in brain slices demonstrate that application of NE partly reverses propofol-induced inhibition of CMT neurons. This study therefore suggests a possible role of the CMT noradrenergic pathway in modulating emergence from propofol anesthesia.
Infusion of NE into the CMT did not change the susceptibility to propofol anesthesia or the time to LORR, but that NE did shorten the time to RORR. These results imply that emergence is not a simple reflection of induction, in line with the suggestion of a previous study that there are differences in the neural substrates of anesthesia induction and recovery (Kelz et al. 2008) . Indeed, Luo and Leung found that orexin-saporin lesion of the tuberomammillary nucleus did not alter the time to LORR following induction with isoflurane, but did delay emergence from anesthesia . Another study showed that lesion of the ventral tegmental area significantly prolonged the emergence time from propofol anesthesia, but did not affect the induction time or the ED50 of propofol (Zhou et al. 2015) . Overall, these findings indicate that the neuronal circuits responsible for induction may differ from those responsible for recovery from anesthesia.
The CMT is a critical component of the intralaminar thalamic complex, which plays an important role in modulation of awareness (Jhangiani-Jashanmal et al. 2016). Our results showed that infusion of NE into the CMT accelerated recovery from propofol anesthesia in rats. At the pharmacological level, Lioudyno et al. (2013) demonstrated that microinjection of the Kv1 channel blocker ShK into the CMT awakens sevoflurane anesthetized rats. Furthermore, another study reported that microinjection of nicotine into the CMT reverses sevoflurane-induced LORR in rats (Alkire et al. 2007) . Based on our results, we propose that the noradrenergic pathway in CMT modulates recovery from propofol anesthesia, but that it is not involved in the induction of propofol anesthesia. Our study therefore confirms and extends the demonstrated role of the CMT in the modulation of arousal during general anesthesia. Noradrenergic fibers from the LC project to midline thalamic nuclei including the CMT, which in turn has fibers projecting to ACC and PFC (Buckwalter et al. 2008; Vogt et al. 2008; Saalmann 2014) . Therefore, in order to examine the effects of these projections to ACC and PFC, we implanted electrodes and measured EEG changes in these regions. We found that infusion of exogenous NE into the CMT not only accelerated recovery from propofol anesthesia, but also elicited changes in the EEG. In the current study, infusion of NE into the CMT increased EEG power in the h frequency band both in PFC and in ACC. However, in ACC but not PFC, it decreased the EEG power in the d frequency band and increased a power, without affecting the power in the b or c frequency bands. We noted that there are some resemblances in EEG changes between NE group and normal emergence group. During propofol anesthesia, infusion of NE into the CMT made the EEG change to the direction of emergence. Similarly, a prior study showed that infusion of histamine into the nucleus basalis magnocellularis (NBM) facilitated emergence from isoflurane anesthesia and increased the EEG power within the d and h frequency bands without altering the EEG power at b or c frequency bands in the left frontal cortex (Luo and Leung 2009 ). Likewise consistent with our results, Pillay and colleagues found that microinfusion of NE into the NBM significantly reduced d power in the frontal cortex of desflurane-anesthetized rats, without altering the power in other frequency bands ). Chen et al. (2016 also found that pharmacogenetic activation of basal forebrain cholinergic neurons decreased delta power in the EEG. Overall, these findings suggest that EEG delta power is related to cortical arousal.
Neuronal oscillations in cortical networks are necessary for information communication and each frequency band may originate from different subcortical structures, with the delta oscillation known to originate in the thalamocortical network (Steriade et al. 1993; Buzsaki and Draguhn 2004) . Previous studies have shown that the deep sedation and unconsciousness caused by propofol are associated with a suppression of thalamocortical functional connectivity (Boveroux et al. 2010; Liu et al. 2013) . We speculate that the EEG changes we observed following infusion of NE into CMT may be correlated with neuronal excitability in CMT. Using the whole-cell current patch clamp, we found that propofol directly hyperpolarized CMT neurons and reduced their firing frequency, while application of NE depolarized CMT neurons and partly reversed the propofol-induced suppression of firing rate. Similarly, a previous study showed that NE depolarizes cholinergic neurons in the NBM in vitro (Fort et al. 1995) . The CMT is part of the medial thalamic nuclei, which are mainly responsible for information transmission and cortical synchrony (Saalmann 2014) . Therefore, we suggest that propofolinduced hyperpolarization may cause changes in the cortical EEG and disturb the process of information transmission and cortical synchrony. These effects of propofol seem to be partly reversed by the action of NE in the CMT.
Propofol is known to enhance GABAergic inhibition in the ventrobasal complex of the thalamus, leading to a decrease in neuronal excitability in thalamocortical relay neurons (Ying et al. 2006) . We propose that propofol may also have generated a similar inhibitory effect on CMT neurons through a potentiation of GABAergic inhibition. In this study, we used the whole-cell voltage patch clamp to observe the influence of propofol and NE on GABA A receptors mediated sIPSCs. Our results showed that propofol increased the frequency, amplitude and prolonged the decay time of sIPSCs, while administration of NE decreased the frequency, without altering the amplitude or decay time. The frequency of sIPSCs is taken as a measure of the presynaptic action, while the amplitude is taken as a measure of the postsynaptic effects (Banks and Pearce 1999) . Our results therefore indicate that propofol facilitates GABAergic transmission in CMT neurons through both presynaptic and postsynaptic mechanisms, but that NE decreases GABAergic transmission primarily through an action on the presynapse. Consistent with our findings, Wakita and colleagues showed that propofol significantly increased the mean amplitude, frequency, and prolonged the decay time of sIPSCs in isolated hippocampal CA3 neurons (Wakita et al. 2013) . Furthermore, a recent study from our group showed that a different GABAergic intravenous anesthetic, etomidate, also enhances GABAergic transmission in the thalamocortical neuronal network (Fu et al. 2016) . Propofol may therefore decrease neuronal excitability in the CMT by enhancing GABAergic inhibition in the thalamus. Based on our results, we speculate that depolarization of CMT neurons and suppression of GABA release from the presynapse may be part of the mechanism through which NE accelerates emergence from propofol anesthesia and elicits changes in the EEG.
In addition to its effects on GABA A receptors, propofol may also act on other targets to suppress neuronal excitability. Ying et al. (2006) showed that the propofol-induced block of Ih contributes to a suppression of neuronal excitability and rhythmic burst firing in thalamocortical neurons. Furthermore, propofol (≥ 3 lM) has been shown to significantly potentiate glycinergic neurotransmission in the spinal cord (Wakita et al. 2016) . Generally, dopamine and NE innervation coincides with the distribution of dopaminergic and noradrenergic receptors, respectively. However, these afferents and their accompanying receptors may be not coincident in some brain areas, perhaps because dopamine receptors can also be activated by NE. Indeed, a recent study showed that NE could also act as a dopamine D2-like receptor agonist (Sanchez-Soto et al. 2016) . As a consequence, we cannot entirely rule out the possibility that infusion of NE activates dopamine receptors in the CMT.
The present study has several limitations. First, the ED50 of propofol was calculated based on successive intraperitoneal injections to reach cumulative doses. Although cumulative intraperitoneal injection of propofol has been widely used in rats to evaluate LORR (Udesky et al. 2005; Laalou et al. 2008; Luo and Leung 2011; Zhou et al. 2015) , the complex pharmacokinetics of intraperitoneal administration may affect the results. Secondly, as in previous studies, we only recorded EEG power changes and did not measure the electromyography changes (Luo and Leung 2009; Leung et al. 2011 Leung et al. , 2013 . Therefore, we do not know whether microinjection of NE induces any changes in muscle tone.
Finally, although we found that infusion of NE into the CMT accelerated emergence from propofol anesthesia, further studies are required to identify the types of neurons in the CMT involved in this process.
Conclusion
Microinjection of NE into the CMT accelerated emergence from propofol anesthesia and elicited EEG changes, but had no impact on anesthesia induction or anesthetic sensitivity to propofol. Propofol suppressed neuronal excitability, likely by enhancing GABAergic inhibition in the CMT, while application of NE partly reversed the inhibitory effect of propofol. These findings support the hypothesis that the CMT noradrenergic pathway plays a role in modulating the emergence from anesthesia.
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Additional Supporting Information may be found online in the supporting information tab for this article: Figure S1 . (a) The effect of different doses of NE on emergence time from propofol anesthesia. Emergence time was shortened by infusion of NE at 0.5, 1.0, and 2.0 lg/lL, but not at 0.1 lg/lL, compared to ACSF, the control (*p < 0.05; n = 3). (b) Propofol dose-dependently decreased firing frequency in the CMT neurons, compared to baseline (*p < 0.05; n = 3). (c) Infusion of NE did not affect the respiratory rate of rats (p > 0.05; n = 10). (d) There was a decrease in d both in emergence and NE group. Figure S2 . The schematic showing the number of rats for every experiment.
